172 related articles for article (PubMed ID: 37925455)
1. Identification of novel diagnostic panel for mild cognitive impairment and Alzheimer's disease: findings based on urine proteomics and machine learning.
Wang Y; Sun Y; Wang Y; Jia S; Qiao Y; Zhou Z; Shao W; Zhang X; Guo J; Zhang B; Niu X; Wang Y; Peng D
Alzheimers Res Ther; 2023 Nov; 15(1):191. PubMed ID: 37925455
[TBL] [Abstract][Full Text] [Related]
2. Urine metabolomics phenotyping and urinary biomarker exploratory in mild cognitive impairment and Alzheimer's disease.
Wang Y; Sun Y; Wang Y; Jia S; Qiao Y; Zhou Z; Shao W; Zhang X; Guo J; Song X; Niu X; Peng D
Front Aging Neurosci; 2023; 15():1273807. PubMed ID: 38187356
[TBL] [Abstract][Full Text] [Related]
3. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
4. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF
J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
6. Association of CSF GAP-43 and
Zhu Y; Guo X; Zhu F; Zhang Q; Yang Y; For The Alzheimer's Disease Neuroimaging Initiative
Cells; 2022 Dec; 12(1):. PubMed ID: 36611808
[TBL] [Abstract][Full Text] [Related]
7. Prognostic classification of mild cognitive impairment and Alzheimer's disease: MRI independent component analysis.
Willette AA; Calhoun VD; Egan JM; Kapogiannis D;
Psychiatry Res; 2014 Nov; 224(2):81-8. PubMed ID: 25194437
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of Alzheimer's Disease Using Quantitative Mass Spectrometry of Human Blood Plasma Proteins and Machine Learning.
Kononikhin AS; Zakharova NV; Semenov SD; Bugrova AE; Brzhozovskiy AG; Indeykina MI; Fedorova YB; Kolykhalov IV; Strelnikova PA; Ikonnikova AY; Gryadunov DA; Gavrilova SI; Nikolaev EN
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887259
[TBL] [Abstract][Full Text] [Related]
9. Identification of Plasma Proteins as Biomarkers for Mild Cognitive Impairment and Alzheimer's Disease Using Liquid Chromatography-Tandem Mass Spectrometry.
Inoue M; Suzuki H; Meno K; Liu S; Korenaga T; Uchida K
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685872
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics Analyses of Saliva Detect Novel Biomarkers of Alzheimer's Disease.
Huan T; Tran T; Zheng J; Sapkota S; MacDonald SW; Camicioli R; Dixon RA; Li L
J Alzheimers Dis; 2018; 65(4):1401-1416. PubMed ID: 30175979
[TBL] [Abstract][Full Text] [Related]
11. Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease.
Giannisis A; Al-Grety A; Carlsson H; Patra K; Twohig D; Sando SB; Lauridsen C; Berge G; Grøntvedt GR; Bråthen G; White LR; Kultima K; Nielsen HM
Alzheimers Res Ther; 2022 Aug; 14(1):115. PubMed ID: 36002891
[TBL] [Abstract][Full Text] [Related]
12. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
[TBL] [Abstract][Full Text] [Related]
13. Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches.
Chang CH; Lin CH; Liu CY; Huang CS; Chen SJ; Lin WC; Yang HT; Lane HY
J Psychopharmacol; 2021 Mar; 35(3):265-272. PubMed ID: 33586518
[TBL] [Abstract][Full Text] [Related]
14. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.
Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN;
Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591
[TBL] [Abstract][Full Text] [Related]
15. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
[TBL] [Abstract][Full Text] [Related]
16. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
[TBL] [Abstract][Full Text] [Related]
17. Regional cerebral perfusion in patients with Alzheimer's disease and mild cognitive impairment: effect of APOE epsilon4 allele.
Kim SM; Kim MJ; Rhee HY; Ryu CW; Kim EJ; Petersen ET; Jahng GH
Neuroradiology; 2013 Jan; 55(1):25-34. PubMed ID: 22828738
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid levels of YKL-40 in prodromal Alzheimer's disease.
Wang L; Gao T; Cai T; Li K; Zheng P; Liu J;
Neurosci Lett; 2020 Jan; 715():134658. PubMed ID: 31794792
[TBL] [Abstract][Full Text] [Related]
19. A Multiplexed Urinary Biomarker Panel Has Potential for Alzheimer's Disease Diagnosis Using Targeted Proteomics and Machine Learning.
Hällqvist J; Pinto RC; Heywood WE; Cordey J; Foulkes AJM; Slattery CF; Leckey CA; Murphy EC; Zetterberg H; Schott JM; Mills K; Paterson RW
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762058
[TBL] [Abstract][Full Text] [Related]
20. Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics.
Gaetani L; Bellomo G; Parnetti L; Blennow K; Zetterberg H; Di Filippo M
Cells; 2021 Jul; 10(8):. PubMed ID: 34440700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
